FDA approves first drug in U.S. with digital ingestion tracking

(Reuters) – The U.S. Food and Drug Administration said on Monday that it had approved Otsuka Pharmaceutical Co Ltd’s Abilify MyCite, the first drug with a digital ingestion tracking system to be approved in the United States.

Source link

Loading Facebook Comments ...

Leave a Reply

Your email address will not be published. Required fields are marked *